News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
191 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18301)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2415)
July (698)
Day
2 (202)
3 (126)
4 (116)
5 (123)
6 (51)
9 (127)
10 (95)
11 (131)
12 (128)
13 (61)
16 (159)
17 (116)
18 (142)
19 (71)
20 (36)
23 (191)
24 (140)
25 (137)
26 (112)
27 (81)
30 (70)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Press Releases
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
June 23, 2025
·
5 min read
Press Releases
Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)
June 23, 2025
·
18 min read
Press Releases
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
June 23, 2025
·
7 min read
Press Releases
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
June 23, 2025
·
19 min read
Press Releases
Quanterix Expands Reach with IVD and Large Reference Labs
June 23, 2025
·
4 min read
Press Releases
Higher dose of semaglutide provided average weight loss of 21% in people with obesity - with a third achieving 25% or more - according to data presented at ADA
June 23, 2025
·
3 min read
Press Releases
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial
June 23, 2025
·
3 min read
Press Releases
Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges
June 23, 2025
·
3 min read
Press Releases
Qlaris Bio to Present New Clinical and Preclinical Data on QLS-111 at 2025 World Glaucoma Congress
June 23, 2025
·
3 min read
Press Releases
AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
June 23, 2025
·
7 min read
Previous
15 of 20
Next
